Anxiety Disorders Clinical Trials

A listing of Anxiety Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

View More ▼

San Diego California 92093

Patients are needed to participate in a clinical research study evaluating Alprazolam (Xanax) and Placebo for the treatment of Generalized Anxiety Disorder

Connecticut

Hartford Connecticut 06106

A Phase 2 clinical study for patients with Phobic Disorders

Florida

Orlando Florida 32816

A clinical research study of Pegasys-VR and Social Effectiveness Therapy for Children for the treatment of Anxiety Disorders

Illinois

Rush University Medical Centre
Chicago Illinois 60612

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Chicago Illinois 60612

A Phase 2 clinical study for patients with Phobic Disorders

Maryland

Bethesda Maryland 20892

A clinical research study of SRX246 and Placebo for the treatment of Fear or Anxiety

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

OCD and Related Disorders Program
Boston Massachusetts 02114

Transcranial Magnetic Stimulation in Obsessive Compulsive Disorder: mechanisms and biomarkers.

Boston Clinical Research
Natick Massachusetts 01760

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Boston Massachusetts 02114

A Phase 2 clinical study for patients with Phobic Disorders

Natick Massachusetts 01760

A Phase 2 clinical study for patients with Phobic Disorders

New York

The Medical Research Network, LLC
New York New York 10128

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

New York New York 10128

A Phase 2 clinical study for patients with Phobic Disorders

Pennsylvania

Lehigh Center For Clinical Research
Allentown Pennsylvania 18104

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Allentown Pennsylvania 18104

A Phase 2 clinical study for patients with Phobic Disorders

Texas

NEW

FutureSearch Trials of Dallas
Dallas Texas 75231

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

Utah

Optimum Clinical Research, Inc.
Salt Lake City Utah 84102

Irritable Bowel Syndrome - Diarrhea Predominant

Australia

Melbourne 3121

A Phase 2 clinical study for patients with Phobic Disorders

Canada

Edmonton Ontario T6L 6W6

A Phase 2 clinical study for patients with Phobic Disorders

Hamilton Ontario L8S 1B7

A Phase 2 clinical study for patients with Phobic Disorders

Mississauga Ontario L5M 4N4

A Phase 2 clinical study for patients with Phobic Disorders

Toronto Ontario M4Y 1H1

A clinical trial to evaluate treatments using Pregabalin and Placebo for patients with Anxiety

Wolfville Nova Scotia B4P 2R6

A clinical trial to evaluate treatments using L. helveticus R0052 and B. longum R0175 and Placebo for patients with Attention Deficit Hyperactivity Disorder or Anxiety

China

Shanghai 200065

A Phase 4 clinical study for patients with Generalized Anxiety Disorder

France

Paris 75000

A clinical research study of Phytostandard® Eschscholtzia / Valerian for the treatment of Sleep Disorders Related to Anxiety

Russian Federation

Kazan' 420101

A Phase 4 clinical study for patients with Anxiety

Korolev 141060

A Phase 4 clinical study for patients with Anxiety

Moscow 115419

A Phase 4 clinical study for patients with Anxiety

Moscow 115516

A Phase 4 clinical study for patients with Anxiety

Smolensk 214018

A Phase 4 clinical study for patients with Anxiety